CANBRIDGE PHARMACEUTICALS INC. (01228)

DirectorFromToPosition(s)Release Date / Document LinksReason for Change
Chan Peng Kuan11-Jun-21INED
Chen Kan16-Dec-2002-Sep-24NEDHe would like to devote more time to his personal engagement
Di Rocco Derek Paul10-Mar-2023-Nov-23NEDHe would like to devote more time to his personal engagement
Dr. Kan Chen02-Sep-24MbACHe would like to devote more time to his personal engagement
Fangxin Li25-Jun-25MbCCResigned due to changes in his work arrangements. Dr. Li confirmed that he had no disagreement with the Board and there were no matters relating to his resignation that should be brought to the attention of the shareholders or The Stock Exchange of Hong Kong Limited.
Geraghty James Arthur18-Jul-18INED
Gregory Richard James21-Apr-2005-Aug-26INEDDue to changes in his personal arrangements.
05-Aug-26ChCCDue to changes in his personal arrangements.
Hu Edward05-Jul-2230-Sep-24NEDDue to changes in his work arrangements.
Hu Lan16-Feb-22INED
James Arthur Geraghty16-Feb-22MbCCNo reasons provided
Keith Shing Cheung Wong01-Apr-22J-CoSec, AuRepNo reasons provided
Le Xiao16-Dec-2005-Jul-22NEDHe intends to focus and devote more time to his other work commitments
Li Fangxin30-Sep-2425-Jun-25NEDResigned due to changes in his work arrangements. Dr. Li confirmed that he had no disagreement with the Board and there were no matters relating to his resignation that should be brought to the attention of the shareholders or The Stock Exchange of Hong Kong Limited.
Ma Qian21-Jun-21CoSec
Moscicki Richard Arthur05-Aug-26INED, ChCC, MbAC
Mr. Edward Hu30-Sep-24MbCCDue to changes in his work arrangements.
Mr. Glenn Hassan30-Sep-24CFODue to personal reasons. Mr. Hassan has confirmed that he has no disagreement with the Board and there are no matters in respect of his resignation that need to be brought to the attention of the shareholders of the Company or The Stock Exchange of Hong Kong Limited.
Qian Ma30-Mar-26AuRep
Richard James Gregory30-Jun-25Member of the Nomination and Corporate Governance CommitteeResigned as a member of the Nomination and Corporate Governance Committee to comply with the requirement to have one director of a different gender in the committee under the revised Corporate Governance Code.
16-Feb-22MbACNo reasons provided
Wong Keith Shing Cheung21-Jun-2101-Apr-22CoSec
Wong Wai Chiu01-Apr-22CoSec
01-Apr-2230-Mar-26J-CoSecMr. Wong tendered his resignation
30-Mar-26AuRep, Proc AgtMr. Wong tendered his resignation
Xiao Le05-Jul-22MbCCHe intends to focus and devote more time to his other work commitments
Xue James Qun30-Jan-18Ch, CEO, Fdr
Zhao Wei30-Jun-25MbCC